[Cell Cycle 5:14, 1492-1495, 15 July 2006]; ©2006 Landes Bioscience
A Novel Link Between SUMO Modification and Cancer Metastasis
Extra ViewSUMO (small ubiquitin-related modifier), a member of ubiquitin-like proteins, modifiesa large number of transcription factors and coregulators. Although ubiquitin and SUMOexhibit structural similarities, the biological output of SUMOylation is somewhat distinctfrom protein degradation that is mainly mediated by ubiquitination. SUMOylation isinvolved in the regulation of the subcellular localization and stabilization of transcriptionalcofactors and chromatin remodeling factors. Given the number of oncogenes and tumorsuppressor genes that have been defined as targets for SUMOylation, studies on proteinSUMOylation may shed light on the mechanism of tumorigenesis and metastasis. Newroles of SUMOylation of a chromatin-remodeling complex have been elucidated. TheSUMOylation status of the reptin chromatin-remodeling complex modulates the KAI1metastasis suppressor gene and the invasive activity of cancer cells with metastaticpotential; this revealed a novel link between SUMO modification and cancer metastasis.Here I overview these findings and discuss biological importance of protein SUMOylationin cancer metastasis.
Original manuscript submitted: 06/06/06Manuscript accepted: 06/07/06
Previously published online as a CellCycleE-publication:
doc.guandang.net
ACKNOWLEDGEMENTS
I thank H. J. Choi for figure illustration. Thiswork was supported by Korea ResearchFoundation Grant, Brain Korea 21 researchfellowship, and the National Research &Development program for cancer control fromMinistry of Health & Welfare.
Metastasis is a fatal and final step in the progression of tumor cells. The metastaticprocess involves several steps including tumor cell intravasations, survival in blood vessels,extravasations into a distant organ, and angiogenesis.1,2However, the mechanisms bywhich alterations occur in tumor cells are largely unknown and have been focused on anddebated for a long time. KAI1 is a member of the structurally distinct family of cell surfaceglycoproteins, the transmembrane 4 protein superfamily, which is capable of inhibiting theprogression of tumor metastasis without affecting primary tumorigenicity in vivo.3,4Downregulation of KAI1 expression has been observed in various human cancers, includingprostate, breast, colon, and ovarian cancers, and KAI1 is a metastasis suppressor implicatedin a variety of biological processes ranging from cell adhesion and migration to signaltransduction.5-7Thus far, the mechanism by which the KAI1gene products modulate andsuppress cancer metastasis has yet to be elucidated. The mechanism by which KAI1 isregulated at not only the translational level but also the transcriptional level would help inunderstanding the suppressive function of KAI1. It appears that this mechanism neitherinvolves a mutation nor an allelic loss, implying that the decrease in KAI1 expression occursat the transcriptional level.4
As major players involved in the transcriptional regulation of KAI1, Tip60, β-catenin,reptin, and pontin have been extensively studied.8-19Tip60 is a coactivator that has anintrinsic histone acetyltransferase activity as well as DNA repair function and is alsoindispensable for KAI1expression.8-11β-Catenin is a coactivator in the Wnt signalingpathway and plays a crucial role in development and homeostasis.18,19Deregulatedβ-catenin expression is involved in oncogenesis and tumor progression.20-23However, thiswell-known coactivator functions as a corepressor in regulation of KAI1, implying adifferential regulation of target genes in the promoter and cellular context.8,9Interestingly,reptin and pontin chromatin remodeling factors are common components of Tip60 andβ-catenin complexes; however these four components have not been detected as one giantcomplex from target gene promoters, as exemplified by KAI1.8Instead, these componentsappear to function in different combinations for the regulation of targets. For example,Tip60 coactivator is responsible for the activation of KAI1promoter, while theβ-catenin-reptin complex mediates the repression of the KAI1promoter.8,9The role ofpontin appears to be unclear at least with respect to the regulation of KAI1, although it is
©
20
1492
06
LA
ND
ES BI
OS
CIE
NC
Cell Cycle
E.
DO
A METASTASIS SUPPRESSOR GENE, KAI1
N
2006; Vol. 5 Issue 14
OT D
SUMO, metastasis, KAI1, chromatin, coacti-vator, corepressor
IST
KEY WORDS
RIBUTE.
Correspondence to: Sung Hee Baek; Department of Biological Sciences; ResearchCenter for Functional Cellulomics; Seoul National University; Seoul 151-742, SouthKorea; Tel.: +82.2.880.9078; Fax: +82.2.886.9078; Email: sbaek@snu.ac.kr
our laboratory showed that HER2 is a novel breast...it is plausible to suggest a link between the ...Cancer Metastasis Rev 14:49–58 O’Brien KM, ...
our laboratory showed that HER2 is a novel breast...it is plausible to suggest a link between the ...Cancer Metastasis Rev 14:49–58 O’Brien KM, ...
热门文档